民祥医药 (834738.OC)

+ 收藏

现金流量表(民祥医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年中报2022年年报2022年三季报2022年中报2022年一季报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 177,801,769.45394,471,472.51219,347,074.49141,180,564.7056,718,673.72
 收到的税费返还(元) 7,636,754.8013,551,907.4310,522,286.504,591,922.752,123,258.04
 收到其他与经营活动有关的现金(元) 1,358,049.1715,453,030.612,531,458.361,540,869.37277,607.53
 经营活动现金流入小计(元) 186,796,573.42423,476,410.55232,400,819.35147,313,356.8259,119,539.29
 购买商品、接受劳务支付的现金(元) 130,929,204.44286,840,179.04150,967,893.93107,684,091.8258,750,698.52
 支付给职工以及为职工支付的现金(元) 33,067,350.0659,758,671.4438,542,166.3427,569,419.3613,245,198.24
 支付的各项税费(元) 9,398,761.572,646,798.642,536,957.031,842,850.39326,061.96
 支付其他与经营活动有关的现金(元) 16,398,277.8038,994,192.2914,026,388.417,302,420.212,072,587.11
 经营活动现金流出小计(元) 189,793,593.87388,239,841.41206,073,405.71144,398,781.7874,394,545.83
 经营活动产生的现金流量净额(元) -2,997,020.4535,236,569.14-2,914,575.04-
二、投资活动产生的现金流量
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) 123,805.8325,000.0025,000.0025,000.00-
 处置子公司及其他营业单位收到的现金净额(元) -53,899,200.0053,899,200.0053,899,200.0053,899,200.00
 投资活动现金流入小计(元) 123,805.8353,924,200.0053,924,200.0053,924,200.0053,899,200.00
 购建固定资产、无形资产和其他长期资产支付的现金(元) 37,281,196.29106,012,433.4192,100,084.4582,735,915.2520,027,518.00
 投资活动现金流出小计(元) 37,281,196.29106,012,433.4192,100,084.4582,735,915.2520,027,518.00
 投资活动产生的现金流量净额(元) -37,157,390.46-52,088,233.41-38,175,884.45-28,811,715.2533,871,682.00
三、筹资活动产生的现金流量
 吸收投资收到的现金(元) 99,999,990.86----
 取得借款收到的现金(元) 170,000,000.00160,426,351.30139,409,122.90121,909,122.907,000,000.00
 收到其他与筹资活动有关的现金(元) -900,000.0031,200,000.0020,000,000.00-
 筹资活动现金流入小计(元) 269,999,990.86161,326,351.30170,609,122.90141,909,122.907,000,000.00
 偿还债务支付的现金(元) 139,838,273.92160,119,179.94192,067,276.40149,501,536.1633,462,866.13
 分配股利、利润或偿付利息支付的现金(元) 8,791,879.8618,948,737.1010,361,748.069,570,078.392,010,612.55
 支付其他与筹资活动有关的现金(元) 8,457,000.005,815,042.273,720,600.003,720,600.00-
 筹资活动现金流出小计(元) 157,087,153.78184,882,959.31206,149,624.46162,792,214.5535,473,478.68
 筹资活动产生的现金流量净额(元) 112,912,837.08-23,556,608.01-35,540,501.56-20,883,091.65-28,473,478.68
四、汇率变动对现金及现金等价物的影响(元) 1,141,522.892,953,012.18255,480.49133,579.14-95,954.93
五、现金及现金等价物净增加额(元) 73,899,949.06-37,455,260.10-47,133,491.88-46,646,652.72-9,972,758.15
 加:期初现金及现金等价物余额(元) 11,891,770.5949,347,030.6949,347,030.6949,347,030.6949,347,030.69
 期末现金及现金等价物余额(元) 85,791,719.6511,891,770.592,213,538.812,700,377.9739,374,272.54
补充资料:
 净利润(元) 11,953,779.9218,631,070.21-5,830,823.11-
 资产减值准备(元) -1,205,183.781,475,683.37--270,476.27-
 固定资产和投资性房地产折旧(元) 13,565,223.5225,951,683.06-12,619,596.22-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 13,565,223.5225,951,683.06-12,619,596.22-
 无形资产摊销(元) 834,389.531,572,088.92-786,044.46-
 长期待摊费用摊销(元) 720,435.872,827,625.40-1,476,161.58-
 处置固定资产、无形资产和其他长期资产的损失(元) 10,989.347,880.25-5,004.14-
 固定资产报废损失(元) -89,324.87---
 财务费用(元) 4,425,613.908,043,315.50-4,103,911.44-
 递延所得税(元) 1,554,773.92-1,381,549.98-101,666.11-
  其中:递延所得税资产减少(元) 1,554,773.92-1,381,549.98-101,666.11-
 存货的减少(元) -14,649,157.64-15,510,070.49--41,096,841.99-
 经营性应收项目的减少(元) 9,891,241.075,134,239.55-41,443,238.75-
 经营性应付项目的增加(元) -30,099,126.10-11,604,721.52--22,084,552.51-
 现金的期末余额(元) 85,791,719.6511,891,770.59-2,700,377.97-
 减:现金的期初余额(元) 11,891,770.5949,347,030.69-49,347,030.69-
 现金及现金等价物的净增加额(元) 73,899,949.06-37,455,260.10--46,646,652.72-
公告日期 2023-08-252023-04-112023-01-182022-08-262022-04-29
审计意见(境内) 标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院